Atara Bio-therapeutics, Inc., a bio-pharmaceutical company, announced the pricing of its underwritten public offering of 3,461,538 shares of its common stock at a public offering price of $52.00 per share.
The offering is expected to close on July 15, 2015, subject to customary closing conditions. The Gross proceeds would be around $180 million.
Goldman, Sachs & Co. and Citigroup Global Markets Inc. are acting as joint book-running managers for the proposed offering. William Blair & Company, L.L.C., Canaccord Genuity Inc. and JMP Securities LLC are acting as co-managers.
View the full release here.